14158 Results (Page 531 of 567)
All Market Research Reports
Egypt Hospital Market Analysis
The Egypt Hospital Market was valued at $15.40 Bn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $28.33 Bn by 2030. The key drivers of this industry are the increasing prevalence of chronic disease, technological advancements, and investment in healthcare infrastructure. The key players in the industry are Cleopatra Hospitals Group, Al Safwa Hospital Group, Zohairy Hospital, and Andalusia Hospital among others.
France Lipid Disorder Therapeutics Market Analysis
The France Lipid Disorder Therapeutics Market was valued at $50.50 Mn in 2023 and is predicted to grow at a CAGR of 12.86% from 2023 to 2030, to $117.78 Mn by 2030. France Lipid Disorder Therapeutics Market is growing due to Escalating Burden of Cardiovascular Disease, Demographic Shift, and Public Awareness. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., AbbVie, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Kenya Hospital Market Analysis
The Kenya Hospital Market was valued at $3.85 Bn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $6.90 Bn by 2030. The key drivers of this industry are increasing demand for quality healthcare, rising prevalence of chronic diseases, and government initiatives. The key players in the industry are Nairobi Hospital, AAR Healthcare, Aga Khan University Hospital, and MP Shah Hospital among others.
Singapore Patient Adherence Programs Market Analysis
The Singapore Patient Adherence Programs Market was valued at $15.5 Mn in 2023 and is predicted to grow at a CAGR of 18.6% from 2023 to 2030, to $51.3 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Singapore Patient Adherence Programs Market are Johnson & Johnson, MSD, Illumina, GSK, Novartis, and Roche, among others.
Egypt Chronic Pain Therapeutics Market Analysis
The Egypt Chronic Pain Therapeutics Market is anticipated to experience a growth from $208 Mn in 2022 to $368 Mn by 2030, with a CAGR of 7.4% during the forecast period of 2022-2030. The key drivers include the rising prevalence of age-related chronic conditions, a growing healthcare expenditure, and a rising awareness leading to a demand for alternative and safer pain management options. The Egypt Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Sanofi, Roche, Merck, Abbott, AstraZeneca, EVA Pharma, Pharco, EIPICO, etc., among various others.
Indonesia Genomics Market Analysis
The Indonesia Genomics market was valued at $195.9 Mn in 2023 and is predicted to grow at a CAGR of 16.5% from 2023 to 2030, to $570.6 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Indonesia genomics market are Pandu Biosains, PT Genetika Science, and Eijkman Institute for Molecular Biology, among others.
India Hospital Market Analysis
The India Hospital Market was valued at $100.01 Bn in 2023 and is predicted to grow at a CAGR of 10.6% from 2023 to 2030, to $202.46 Bn by 2030. The key drivers of this industry are the increasing prevalence of chronic disease, technological advancements, and government initiatives. The key players in the industry are Max Healthcare, Sterling Hospitals, Manipal Hospitals, and CARE Hospitals among others.
France Patient Adherence Programs Market Analysis
The France Patient Adherence Programs Market was valued at $356.3 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $1,069.3 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the France Patient Adherence Programs Market are Takeda, Pfizer, Sanofi, Novartis among others
South Africa Hospital Market Analysis
The South Africa Hospital Market was valued at $35.75 Bn in 2023 and is predicted to grow at a CAGR of 8.83% from 2023 to 2030, to $64.64 Bn by 2030. The key drivers of this industry are the rise in geriatric population, technological advancements, and burden of chronic diseases. The key players in the industry are Netcare Group, Mediclinic Southern Africa, Busamed, and Melomed Group among others.
Indonesia Chronic Pain Therapeutics Market Analysis
The Indonesia Chronic Pain Therapeutics Market is anticipated to experience a growth from $446 Mn in 2022 to $705 Mn by 2030, with a CAGR of 5.9% during the forecast period of 2022-2030. An aging population with rising chronic pain, growing awareness among healthcare professionals and patients, and supportive government initiatives are the key drivers of this market. The Indonesia Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, Abbott, AstraZeneca, Bristol Myers Squibb, Roche, Johnson & Johnson, Kalbe Pharma, Indo Pharma, Kimia Pharma, Tempo Scan Group, etc., among various others.
Malaysia Genomics Market Analysis
The Malaysia Genomics market was valued at $52.5 Mn in 2023 and is predicted to grow at a CAGR of 16.70% from 2023 to 2030, to $154.7 Mn by 2030. The key drivers of the market include increasing incidence and prevalence of cancer, the need for advancements in cancer treatments, and the increasing trend of personalized medicines. The prominent players of the Malaysia genomics market are Malaysian Genomics Resource Centre, Codon Genomics, MyTACG Bioscience, Genesis Genome, and Genetics Healthcare Centre, among others.
Canada Dental Fluoride Treatment Market Analysis
The Canada Dental Fluoride Treatment Market was valued at $1,213.4 Mn in 2023 and is projected to grow at a CAGR of 3.9% from 2023 to 2023, to $1,586 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Colgate, 3M, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
Germany Patient Adherence Programs Market Analysis
The Germany Patient Adherence Programs Market was valued at $474.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $1,356.4 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players of the Germany Patient Adherence Programs Market are
Japan Chronic Pain Therapeutics Market Analysis
The Japan Chronic Pain Therapeutics Market is anticipated to experience a growth from $4.618 Bn in 2022 to $7.586 Bn by 2030, with a CAGR of 6.4% during the forecast period of 2022-2030. The market is primarily driven by the rapidly aging population leading to an increased prevalence of chronic pain conditions, augmented healthcare expenditure, government support prioritizing pain management accessibility, and a growing demand for non-opioid alternatives. The Japan Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AstraZeneca, Sanofi, Merck, Roche, AbbVie, Astellas, Chugai Pharmaceuticals, Daiichi Sankyo, Eisai, etc., among various others.
Philippines Genomics Market Analysis
The Philippines Genomics market was valued at $71.8 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $215.6 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Philippines genomics market are PHIX Genomics, Philippine Genome Centre (PGC), Department of Science and Technology (DOST), Institute of Human Genetics (IHG), among others.
US Dental Fluoride Treatment Market Analysis
The US Dental Fluoride Treatment Market was valued at $6,370.2 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $7,267.3 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Procter & Gamble, Colgate Palmolive, Unilever, 3M and Ultradent Products among others.
US Financial Assistance Programs Market Analysis
The US Financial Assistance Programs Market was valued at $11,902.5 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $27,315.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
Saudi Arabia Dental Fluoride Treatment Market Analysis
The Saudi Arabia Dental Fluoride Treatment Market was valued at $257.8 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $372.6 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Procter & Gamble, Colgate-Palmolive Company, Unilever PLC, Sensodyne, Arm & Hammer and Aquafresh among others.
Mexico Chronic Pain Therapeutics Market Analysis
The Mexico Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.115 Bn in 2022 to $1.797 Bn by 2030, with a CAGR of 6.15% during the forecast period of 2022-2030. The key drivers include the escalating risk factors associated with evolving lifestyles and occupational hazards, a shifting preference towards patient-centered care, and ongoing research and development efforts aimed at innovative therapies and precision medicine applications. The Mexico Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Novartis, Merck, GSK, Sanofi, Genomma Lab, Silanes, SOMAR Group, Laboratorios Grin, etc., among various others.
Singapore Genomics Market Analysis
The Singapore Genomics market was valued at $39.2 Mn in 2023 and is predicted to grow at a CAGR of 17.10% from 2023 to 2030, to $118.3 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Singapore genomics market are the Genome Institute of Singapore (GIS), NovogeneAIT Genomics, Molecular Genomics, and ACT Genomics, among others.
UAE Dental Fluoride Treatment Market Analysis
The UAE Dental Fluoride Treatment Market was valued at $75.8 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $106 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Julphar Gulf Pharmaceuticals, Dabur International, Colgate, Philips, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
Saudi Arabia Financial Assistance Programs Market Analysis
The Saudi Arabia Financial Assistance Programs Market was valued at $481.8 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $1,369.8 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Takeda Pharmaceuticals, Teva Pharmaceuticals, GSK, Novartis among others.
Philippines Chronic Pain Therapeutics Market Analysis
The Philippines Chronic Pain Therapeutics Market is anticipated to experience a growth from $163 Mn in 2022 to $269 Mn by 2030, with a CAGR of 6.4% during the forecast period of 2022-2030. The key drivers include untreated cases due to limited healthcare accessibility and misconceptions, an increasing burden of chronic diseases contributing to a higher demand for pain management solutions, and advancements in healthcare technologies. The Philippines Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AstraZeneca, Sanofi, Merck, Roche, AbbVie, Bayer, Taisho Pharmaceuticals, Unilab, Multicare Pharmaceuticals, etc., among various others.
South Africa Genomics Market Analysis
The South Africa Genomics market was valued at $212.2 Mn in 2023 and is predicted to grow at a CAGR of 17.73% from 2023 to 2030, to $665.3 Mn by 2030. The key drivers of the market include the need for advancements in cancer treatments, rising burden of Non-Communicable Diseases (NCDs), and increasing trend of personalized medicines. The prominent players of the South Africa Genomics Market are the South African National Bioinformatics Institute (SANBI), South African Medical Research Council (SAMRC), Illumina, Thermo Fisher Scientific, and Qiagen, among others.
Brazil Dental Fluoride Treatment Market Analysis
The Brazil Dental Fluoride Treatment Market was valued at $379.2 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $530 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Fresh Up Italia, Procter & Gamble Company, Fresh, Colgate-Palmolive and Johnson & Johnson among others.
